Cerus Endovascular, now part of Stryker, is dedicated to transforming interventional neuroradiology. On May 2, 2023, Stryker Corporation completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage, medical device company founded in 2011. They are engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms.
Follow the Stryker Neurovascular LinkedIn page for the latest on Cerus Endovascular products. The company is focused on the novel design and manufacturing of innovative intra-saccular technologies for the Neurovascular marketplace. Their industries include Biotechnology and Health Care, and they are headquartered in the United States.
The company's last investment was a Series B investment on 21 February 2020. The investors for this round are not provided. This strategic acquisition by Stryker Corporation positions Cerus Endovascular to further advance its mission of driving innovation and improving patient outcomes in the field of interventional neuroradiology.
No recent news or press coverage available for Cerus Endovascular, now part of Stryker.